Compare GLP & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLP | PLSE |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2005 | 2016 |
| Metric | GLP | PLSE |
|---|---|---|
| Price | $42.70 | $14.46 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $45.00 | $22.00 |
| AVG Volume (30 Days) | 41.0K | ★ 182.7K |
| Earning Date | 11-07-2025 | 11-05-2025 |
| Dividend Yield | ★ 7.16% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.08 | N/A |
| Revenue | ★ $18,099,776,000.00 | $86,000.00 |
| Revenue This Year | $22.70 | N/A |
| Revenue Next Year | $42.12 | $1,002.94 |
| P/E Ratio | $20.28 | ★ N/A |
| Revenue Growth | ★ 4.10 | N/A |
| 52 Week Low | $39.70 | $12.56 |
| 52 Week High | $60.00 | $25.00 |
| Indicator | GLP | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 40.13 | 51.85 |
| Support Level | $41.76 | $13.94 |
| Resistance Level | $46.00 | $14.70 |
| Average True Range (ATR) | 1.65 | 0.64 |
| MACD | -0.14 | 0.23 |
| Stochastic Oscillator | 9.91 | 78.89 |
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.